City of Hope

City of Hope, a NCI-designated Comprehensive Cancer Center

Page Title

Skip Navigation

Global Navigation



Border Border
  
  PROFILE 
The following is a list of available studies directed by  Anthony Stein, MD  
Search results:  8  Clinical trial(s) found  (Page 1 of 1 )
Results per page: 25 50 100 All 1-8 Trials Jump to page:

COH Protocol Number: 14352 ClinicalTrials.gov Number: NCT01915498

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, Pharmacodynamic, and Clinical Activity Study of Orally Administered AG-221 in Subjects with Advanced Hematologic Malignancies with an IDH2 Mutation

COH Protocol Number: 14301 ClinicalTrials.gov Number: NCT02270463

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  A Phase 1/2 Study of SL-401 as Consolidation Therapy for Adult Patients with Adverse Risk Acute Myeloid Leukemia in First CR, and/or Evidence of Minimal Residual Disease (MRD) in First CR

COH Protocol Number: 14294 ClinicalTrials.gov Number: NCT02326584

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  A Phase 1b Dose-Escalation Study of SGN-CD33A in Combination with Standard-of-Care for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

COH Protocol Number: 14293 ClinicalTrials.gov Number: NCT02351037

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  A Multicenter Open-Label Phase 2a Study of Ibrutinib With or Without Cytarabine in Subjects with Acute Myeloid Leukemia

COH Protocol Number: 14012 ClinicalTrials.gov Number: NCT02094794

Principal Investigator: Anthony Stein, MD
Sponsor: Institutional

Title:  Phase II Study of Total Marrow and Lymphoid Irradiation (TMLI) Given in Combination with Cyclophosphamide and Etoposide as Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with High-Risk Acute Lymphocytic or Myelogenous Leukemia

COH Protocol Number: 13474 ClinicalTrials.gov Number: NCT02113982

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  SL-401 in Patients with Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm

COH Protocol Number: 13175 ClinicalTrials.gov Number: NCT01902329

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  A Phase I Trial of SGN-CD33A in Patients with CD33-Positive Acute Myeloid Leukemia

COH Protocol Number: 13167 ClinicalTrials.gov Number: NCT01363297

Principal Investigator: Anthony Stein, MD
Sponsor: Industrial

Title:  An Open-Label, Phase 1/2 Study of Inotuzumab Ozogamicin in Subjects With Relapsed or Refractory CD22-Positive Acute Lymphocytic Leukemia

 
Results per page: 25 50 100 All 1-8 Trials Jump to page:

 
 
  
NCI CCC LogoCity of Hope, An NCI-designated Comprehensive Cancer Center, is an innovative biomedical research, treatment and educational institution dedicated to the prevention and cure of cancer and other life-threatening illness.
Best Of logoCity of Hope has been named one of "America's Best Hospitals" in cancer and gynecology by U.S. News & World Report. Read more here...
NCI CCC LogoThe National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HONcode of the Healthcare on the Net Foundation.